Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting

Clinical Microbiology and Infection

Volumn 21, Issue 5, 2015, Pages 472.e7-472.e10

  Catho, G ^a,b   Couraud, S ^c   Grard, S ^a   Bouaziz, A ^a   Senechal A ^a   Valour, F ^a   Perpoint, T ^a   Braun, E ^a   Biron, F ^a   Ferry, T ^a,d   Chidiac, C ^a   Freymond, N ^c   Perrot, E ^c   Souquet, P J ^c   Tronc, F ^e   Veziris, N ^f,g   Lina, G ^c,d   Dumitrescu, O ^c,d   Ader, F ^a,d   Boibieux, A ^g   Bouledrak, K ^g   Carret, G ^g   Charhon, N ^g   Chumbi Flores, W ^g   Devouassoux, G ^g   Ernesto, S ^g   Floret, D ^g   Gardes, S ^g   Gerbier Colomban, S ^g   Gillet, Y ^g   Goutelle, S ^g   Grando, J ^g   Grima, R ^g   Hees, L ^g   Karsenty, J ^g   Kiakouama Maleka, L ^g   Maury, M ^g   Metzger, H ^g   Miailhes, P ^g   Moreau, L ^g   Nesme, P ^g   Peyramond, D ^g   Ranc, G ^g   Reix, R ^g   Renaud Baron, S ^g   Thai, H van ^g   Vanhems, P ^g   more..

^a CROIX ROUSSE HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Assistance publique Hôpitaux de Paris   (France)

Author keywords

Bedaquiline; MDR TB surgery; Multidrug resistant tuberculosis; Mycobacterium tuberculosis; Negative pressure ventilation room

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; BEDAQUILINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; CHRONIC PATIENT; CLINICAL ARTICLE; CYTOPENIA; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTRITIS; HEARING IMPAIRMENT; HEPATITIS; HUMAN; HYPOTHYROIDISM; INDIVIDUALIZATION; MALE; MENTAL DISEASE; MULTIDRUG RESISTANT TUBERCULOSIS; MUSCULOSKELETAL PAIN; NAUSEA; NEPHROTOXICITY; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING; CASE MANAGEMENT; COMMUNICABLE DISEASES, EMERGING; ORGANIZATION AND MANAGEMENT; PERSONALIZED MEDICINE; PROCEDURES; RETROSPECTIVE STUDY; SURGERY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CASE MANAGEMENT; COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMANS; MALE; PRECISION MEDICINE; PREVALENCE; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84930526975     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.12.022     Document Type: Article

References (19)

1. Global tuberculosis report 2014 2014, World Health Organization, World Health Organization, Geneva.
2. Udwadia Z.F., Amale R.A., Ajbani K.K., Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis 2012, 54:579-581.
3. Johnston J.C., Shahidi N.C., Sadatsafavi M., Fitzgerald J.M. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 2009, 4:e6914.
4. Bernard C., Brossier C., Sougakoff W., Veziris N., Frechet-Jachym M., Metivier N., et al. Asurge of MDR and XDR tuberculosis in France among patients born in the former Soviet Union. Euro Surveill 2013, 18:20555.
5. Sotgiu G., Centis R., D'Ambrosio L., et al. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J 2010, 36:208-211.
6. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs 2008, World Health Organization, WHO, Geneva.
7. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. JClin Microbiol 1997, 35:907-914.
8. Vitol I., Driscoll J., Kreiswirth B., Kurepina N., Bennett K.P. Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol 2006, 451-504.
9. Langlois-Klassen D., Kunimoto D., Saunders L.D., Chui L., Boffa J., Menzies D., et al. Apopulation-based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country?. PLoS One 2012, 7:e38431.
10. López B., Aguilar D., Orozco H., Burger M., Espitia C., Ritacco V., et al. Amarked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003, 133:30-37.
11. Parwati I., van Crevel R., van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 2010, 10:103-111.
12. Falzon D., Jaramillo E., Schünemann H.J., Arentz M., Bauer M., Bayona J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011, 38:516-528.
13. Sturdy A., Goodman A., José R.J., Loyse A., O'Donoghue M., Kon O.M., et al. Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. JAntimicrob Chemother 2011, 66:1815-1820.
14. Sotgiu G., Centis R., D'Ambrosio L., Alffenaar J.W., Anger H.A., Caminero J.A., et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012, 40:1430-1442.
15. Diacon A.H., Pym A., Grobusch M., Patientia R., Rustomjee R., Page-Shipp L., et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. NEngl J Med 2009, 360:2397-2405.
16. Diacon A.H., Pym A., Grobusch M.P., de los Rios J.M., Gotuzzo E., Vasilyeva I., et al. Multidrug-resistant tuberculosis and culture conversion with Bedaquiline. NEngl J Med 2014, 371:723-732.
17. Cohen J. Infectious disease. Approval of novel TB drug celebrated-with restraint. Science 2013, 339(6116):130.
18. Marrone M.T., Venkataramanan V., Goodman M., Hill A.C., Jereb J.A., Mase S.R. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2013, 17:6-16.
19. Laserson K.F., Thorpe L.E., Leimane V., Weyer K., Mitnick C.D., Riekstina V., et al. Speaking the same language: Treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005, 9:640-645.